Juno Therapeutics, Inc. 4
4 · Juno Therapeutics, Inc. · Filed Feb 4, 2016
Insider Transaction Report
Form 4
Levitsky Hyam
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2016-02-02+100,000→ 100,000 totalExercise: $24.50Exp: 2026-02-01→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]1/48 of the shares subject to the option become vested and exercisable on March 2, 2016 and 1/48 of the shares subject to the option shall vest monthly thereafter.